VITA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.604
AS - Asia 1.475
EU - Europa 1.443
SA - Sud America 172
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 3
AN - Antartide 1
Totale 6.741
Nazione #
US - Stati Uniti d'America 3.460
CN - Cina 660
RU - Federazione Russa 408
SG - Singapore 406
DE - Germania 235
IT - Italia 219
BR - Brasile 145
CA - Canada 122
UA - Ucraina 115
HK - Hong Kong 103
GB - Regno Unito 101
VN - Vietnam 96
SE - Svezia 83
FR - Francia 76
FI - Finlandia 68
KR - Corea 43
IN - India 40
TR - Turchia 37
IE - Irlanda 27
CZ - Repubblica Ceca 24
PL - Polonia 24
JP - Giappone 23
ZA - Sudafrica 19
MX - Messico 18
ES - Italia 15
BE - Belgio 13
IQ - Iraq 10
BD - Bangladesh 9
EU - Europa 9
AR - Argentina 8
IR - Iran 8
NL - Olanda 7
VE - Venezuela 6
CO - Colombia 5
ID - Indonesia 5
LT - Lituania 5
AT - Austria 4
EG - Egitto 4
IL - Israele 4
RO - Romania 4
UY - Uruguay 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
MA - Marocco 3
MY - Malesia 3
NP - Nepal 3
PK - Pakistan 3
TW - Taiwan 3
DK - Danimarca 2
EC - Ecuador 2
KE - Kenya 2
KG - Kirghizistan 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
TN - Tunisia 2
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.741
Città #
Ashburn 311
Jacksonville 289
Woodbridge 228
Chandler 201
Singapore 197
Houston 178
San Jose 169
Fairfield 168
Ann Arbor 146
Dallas 138
Boardman 123
Council Bluffs 111
Beijing 107
Wilmington 99
Hong Kong 98
Nanjing 83
Toronto 77
Seattle 75
The Dalles 62
Los Angeles 61
Cambridge 59
New York 57
San Mateo 54
Ho Chi Minh City 41
Nanchang 41
Seoul 38
Columbus 37
Lawrence 36
Princeton 36
Tongling 36
Lauterbourg 33
Düsseldorf 32
Dearborn 30
Helsinki 29
Istanbul 29
Ogden 27
Dublin 25
Lachine 25
Buffalo 24
Tianjin 24
Washington 23
Orem 21
Shanghai 21
São Paulo 21
Hanoi 20
Redwood City 20
Acquaviva 19
Hebei 19
Santa Clara 19
Johannesburg 17
Guangzhou 16
Milan 16
Chicago 15
Tokyo 15
Leawood 14
London 14
Moscow 14
Shenyang 14
Brussels 13
Kunming 13
Bremen 12
Brno 12
Camerino 12
Chennai 12
Jiaxing 12
Atlanta 11
Changsha 11
Hangzhou 11
Jinan 11
Brooklyn 10
Kraków 10
Montreal 10
Mumbai 10
Nürnberg 10
Olomouc 10
Stockholm 10
Warsaw 10
Changchun 8
Frankfurt am Main 8
Manchester 8
Mexico City 8
San Francisco 8
Ankara 7
Ardabil 7
Augusta 7
Munich 7
Sapporo 7
Zhengzhou 7
Denver 6
Monmouth Junction 6
Rio de Janeiro 6
Stuttgart 6
Venezia 6
Wuhan 6
Baghdad 5
Falls Church 5
Indianapolis 5
Rome 5
Verona 5
Cagliari 4
Totale 4.309
Nome #
2’-C-Methyl derivatives of tecadenoson and 2-chloro-tecadenoson with increased selectivity for human A1 adenosine receptor 253
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 238
ATP-mimetics derived from 2 '(3 ')-C-methyladenosine as human P2Y2 agonists 235
5’-deoxy-5’-N-pyrazolyl-N6-substituded adenosine derivates as A1 adenosine receptor agonists: synthesis and antinociception in mice 235
ADP- and ATP-mimetics derived from 2'(3')-C-methyladenosine as human P2Y1 and P2Y2 receptor ligands 225
5'-CHLORO-5'-DEOXY-N6-(±)-endo-NORBORNYLADENOSINE, A POTENT AND HIGHLY SELECTIVE HUMAN A1 ADENOSINE RECEPTOR AGONIST, PREVENTS HYPERALGESIA/ALLODYNIA AND EARLY OVER-EXPRESSION OF PRO-APOPTOTIC AND PRO-INFLAMMATORY GENES IN A MICE MODEL OF NEUROPATHIC PAIN 224
Synthesis and Biological Evaluation of NAD Analogs as Human Pyridine Nucleotide Adenylyltransferase Inhibitors 217
Novel Inhibitors of Inosine Monophosphate Dehydrogenase in Patent Literature of the Last Decade 216
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 216
Synthesis and biological activity of novel N6-substituted and 2,N6-disubstituted adenine ribo- and 3'-C-methyl-ribonucleosides as antitumor agents 215
N6/5’-DISUBSTITUTED ADENOSINE AND 2-CHLORO-ADENOSINE DERIVATIVES AS POTENT AND SELECTIVE A1 ADENOSINE RECEPTOR AGONISTS: SYNTHESIS, BINDING ASSAYS AND ANTINOCICEPTIVE ACTIVITY IN MICE 208
Purine and pyrimidine nucleoside analogs of 3'-C-methyladenosine as antitumor agents 206
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir 206
Stereoselective synthesis of nicotinamide β-riboside and nucleoside analogs 204
5’-CHLORO-5’-DEOXY-N6-SUBSTITUTED ADENOSINE DERIVATIVES: SYNTHESIS, ADENOSINE RECEPTOR AFFINITY AND ANTINOCICEPTIVE ACTIVITY 204
5'-Chloro-5'-deoxy-N6-(±)-endo-norbornyladenosine, a potent and highly selective human A1 adenosine receptor agonist modulates neuropathic pain in mice. 202
Synthesis and antitumor activity of a heterodinucleotide of BVDU and Gemcitabine 194
Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors 191
Affinity and selectivity of tecadenoson, 2-chloro-tecadenoson and 2’-C-methyl analogues at bovine and pig A1 adenosine receptor 186
First TiCl4-Mediated Diastereoslective Reduction of alpha-Nitro Ketones to beta-Nitro Alcohols by BH3.SMe2 186
3’-C-Methyl-ribosyl nucleosides as cytotoxic compounds 181
Ribose-modified mizoribine analogues: synthesis and biological evaluation 177
Selective inhibition of nicotinamide adenine kinases (NADKs) by compact NAD mimics 174
Bisphosphonate Derivatives of 2’-C-Methyl-, and 3’-C-Methyl-Adenosine as Ligands at P2Y1 and P2Y2 Receptors 171
NOVEL 2-SUBSTITUTED 2’/3’-C-METHYL-ADENOSINE DERIVATIVES: SYNTHESIS AND BIOLOGICAL EVALUATION AGAINST TRYPANOSOMA BRUCEI 168
Sugar-modified nucleosides: synthesis, conformational analysis and biological evaluation 168
ADP-, and ATP-mimetics derived from 2'(3')-C-methyladenosine as human P2Y1 and P2Y2 ligands 167
Synthesis and biological evaluation of (methylene)bisphosphonate derivatives of 2’-C-methyl-, and 3’-C-methyl-adenosine 165
EFFECTS OF METAL(III) COORDINATION ON BIOLOGICAL ACTIVITY OF 2,2'-BIPYRIDYL-6-CARBOTHIOAMIDE (BPYTA), A POTENT R2 RIBONUCLEOTIDE REDUCTASE INHIBITOR 161
Structure-affinity relathionships of 5'-carbamoyl- and 5'-thionocarbamoyl derivatives of the A1 selective adenosine receptor agonist 2'-MeCCPA as partial A1 agonists 160
Design, synthesis and biological evaluation of novel inhibitors of NAD kinase 160
N6/5’-DISUBSTITUTED ADENOSINE AND 2-CHLORO-ADENOSINE DERIVATIVES AS POTENT AND SELECTIVE A1 ADENOSINE RECEPTOR AGONISTS: SYNTHESIS, BINDING ASSAYS AND ANTINOCICEPTIVE ACTIVITY IN MICE 153
Synthesis and Enzymatic Evaluation of NAD Mimics as Nicotinamide Adenine Dinucleotide Kinase (NADK) Inhibitors 148
Dual-target dimeric molecules with antitumor properties. Synthesis and biological activity of 3’-C-methyladenosine-valproates 145
PROBING BINDING REQUIREMENTS OF NAD KINASE WITH MODIFIED NAD ANALOGUES 140
New N6-substituted adenosine and 3’-C-methyl-adenosine derivatives as antitumor agents 127
Totale 6.826
Categoria #
all - tutte 26.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022354 25 103 6 20 17 23 11 23 30 26 29 41
2022/2023546 68 15 33 71 53 77 1 41 105 27 38 17
2023/2024476 60 29 34 5 24 77 17 23 39 24 9 135
2024/20251.258 58 28 114 50 53 69 193 290 121 72 61 149
2025/20261.653 95 149 155 260 193 140 229 77 61 146 85 63
2026/202770 70 0 0 0 0 0 0 0 0 0 0 0
Totale 6.826